Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Sales: 2020-2024

Historic Return on Sales for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -0.26%.

  • Journey Medical's Return on Sales rose 17.00% to -0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.14%, marking a year-over-year increase of 17.00%. This contributed to the annual value of -0.26% for FY2024, which is 21.00% down from last year.
  • According to the latest figures from FY2024, Journey Medical's Return on Sales is -0.26%, which was down 437.14% from -0.05% recorded in FY2023.
  • Over the past 5 years, Journey Medical's Return on Sales peaked at 0.11% during FY2020, and registered a low of -0.70% during FY2021.
  • Moreover, its 3-year median value for Return on Sales was -0.26% (2024), whereas its average is -0.24%.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by 81bps in 2021, then skyrocketed by 35bps in 2023.
  • Yearly analysis of 5 years shows Journey Medical's Return on Sales stood at 0.11% in 2020, then tumbled by 81bps to -0.70% in 2021, then grew by 29bps to -0.40% in 2022, then spiked by 35bps to -0.05% in 2023, then decreased by 21bps to -0.26% in 2024.